Department of Endocrinology and Metabolic Diseases, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Health Management Center, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Eur J Med Res. 2023 Nov 25;28(1):540. doi: 10.1186/s40001-023-01520-w.
Activating transcription factor 6 (ATF6) is an endoplasmic reticulum stress responsive gene. We previously reported that conditional knockout of hepatic ATF6 exacerbated liver metabolic damage by repressing autophagy through mTOR pathway. However, the mechanism by which ATF6 influence liver metabolism has not been well established. Hydrogen sulfide (HS) is a gaseous signaling molecule that plays an important role in regulating inflammation, and suppress nonalcoholic fatty liver in mice. Based on the previous study, we assumed that ATF6 may regulate HS production to participate in liver metabolism. In order to clarify the mechanism by which ATF6 regulates HS synthesis to ameliorate liver steatosis and inflammatory environment, we conducted the present study. We used the liver specific ATF6 knockout mice and fed on high-fat-diet, and found that HS level was significantly downregulated in hepatic ATF6 knockout mice. Restoring HS by the administration of slow HS releasing agent GYY4137 ameliorated the hepatic steatosis and glucose tolerance. ATF6 directly binds to the promoter of cystathionine β synthetase (CBS), an important enzyme in HS synthesis. Thus, ATF6 could upregulate HS production through CBS. Sulfhydrated Sirtuin-1 (SIRT1) was downregulated in ATF6 knockout mice. The expression of pro-inflammatory factor IL-17A was upregulated and anti-inflammatory factor IL-10 was downregulated in ATF6 knockout mice. Our results suggest that ATF6 can transcriptionally enhance CBS expression as well as HS synthesis. ATF6 increases SIRT1 sulfhydration and ameliorates lipogenesis and inflammation in the fatty liver. Therefore, ATF6 could be a novel therapeutic strategy for high-fat diet induced fatty liver metabolic abnormalities.
激活转录因子 6(ATF6)是内质网应激反应基因。我们之前的研究报道,通过 mTOR 通路抑制自噬,肝 ATF6 条件性敲除加重了肝代谢损伤。然而,ATF6 影响肝代谢的机制尚未得到很好的阐明。硫化氢(HS)是一种气态信号分子,在调节炎症和抑制小鼠非酒精性脂肪肝中发挥重要作用。基于之前的研究,我们假设 ATF6 可能通过调节 HS 产生来参与肝代谢。为了阐明 ATF6 调节 HS 合成以改善肝脂肪变性和炎症环境的机制,我们进行了本研究。我们使用肝特异性 ATF6 敲除小鼠并给予高脂肪饮食,发现肝 ATF6 敲除小鼠中 HS 水平显著下调。通过给予缓慢释放 HS 的试剂 GYY4137 来恢复 HS,可改善肝脂肪变性和葡萄糖耐量。ATF6 直接结合到 HS 合成中重要酶胱硫醚β合酶(CBS)的启动子上。因此,ATF6 可以通过 CBS 上调 HS 产生。ATF6 敲除小鼠中硫代化 Sirtuin-1(SIRT1)下调。ATF6 敲除小鼠中促炎因子 IL-17A 的表达上调,抗炎因子 IL-10 的表达下调。我们的结果表明,ATF6 可以转录增强 CBS 表达和 HS 合成。ATF6 增加 SIRT1 硫代化,改善脂肪肝中的脂肪生成和炎症。因此,ATF6 可能成为治疗高脂肪饮食诱导的脂肪肝代谢异常的新策略。